Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000562 Antibody formulations

Patent 10000562 was granted and assigned to Genentech on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100005620

Patent Inventor Names

Ajay Deshmukh0

Thomas M. Scherer0

Joumana Zeid0

Date of Patent

June 19, 2018

Patent Application Number

142598820

Date Filed

April 23, 2014

Patent Citations Received

‌

US Patent 11660343 Viscosity-reducing excipient compounds for protein formulations

‌

US Patent 11696951 Viscosity-reducing compounds for protein formulations

‌

US Patent 11357857 Excipient compounds for protein processing

‌

US Patent 11634485 Therapeutic antibody formulation

‌

US Patent 11672865 Viscosity-reducing excipient compounds for protein formulations

Patent Primary Examiner

‌

Bridget E Bunner

Patent abstract

Formulations comprising an anti-IL-13 antibody are provided, including pharmaceutical formulations and methods of using such formulations.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000562 Antibody formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API